The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
about
Focus on adoptive T cell transfer trials in melanomaCloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumorA new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasProgress and controversies in developing cancer vaccines.Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyA randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas.MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and BevacizumabVEGFR-2 expression in human melanoma: revised assessment.The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1REvaluation of molecular markers of mesenchymal phenotype in melanoma.Strategies and challenges in eliciting immunity to melanoma.Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoidsAnalysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansionChanges in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survivalT-cell antigens in cancerHuman CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLAThe tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crestCharacterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytesMelanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γImmunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
P2860
Q21328679-9AE9D694-4808-4751-AB5C-AEACBEEF61EAQ24312048-85AC7922-8BA9-4080-9BCC-7146905367F7Q24679739-B87BC558-3180-4C08-9C55-F91718727E48Q24810256-3872776A-82F5-4424-B7F6-237122649E20Q28548486-2354D79C-EBBC-43AD-99C9-57DA47BA54B6Q30305530-F4DF7BA0-5919-4800-8CB4-3AFA3186B0C2Q30411499-62002A9B-5017-4568-8342-29EF4478004AQ30412235-8736A8BD-6EA6-46F6-ADCE-97AE0ED6E245Q30415894-A09A811F-5558-4F47-81F7-6B932DEBFD7CQ30423356-164B4178-441A-4DB4-ADFD-74DA9786925FQ30425111-21DE9D00-FD6C-4004-9F6A-CE04D82850FEQ30425784-A2098E90-A33A-46DC-8131-4B86860125CCQ30429385-C7BF7415-60D4-4AB6-A0D0-D53AE3CCAB2DQ30435893-5F3D08D6-B94A-4BA5-B4E9-ACFC1CED235DQ30438929-713F3FF5-7785-454D-B57B-E4EB85ED11D2Q33769116-51D6CA7D-A22B-43A7-B2EC-034887D777EAQ33894139-1734CA66-59C8-4C94-85CF-4ECB073E4691Q34153753-A9CF4380-3075-4AEA-8153-44748E069192Q35179337-BB8E56AD-9726-4536-A80A-4DF7F98387F6Q35789284-97673C50-E8B7-445F-B736-B9BA6D2AB6AAQ35983100-A3DDF169-6834-497E-B235-2397157FC907Q36238343-4A35C053-9D07-4B6D-A1A3-22ED0FEE0119Q36362111-AB1BD838-B385-48F4-A2BD-C862224A4A22Q36470250-EB51463F-4E9A-401B-B32E-E588BF41AC0BQ36621391-04C70115-6ED0-4C24-B44C-B471E90A1B69Q37324783-0E8CF287-B2C3-4A5A-B736-12476A23E491Q37635491-5E2B47BD-770E-4BC8-AD5F-22516051837BQ37701554-61A50979-AAD3-413F-914C-38F4B80804F8Q39850341-A74359B1-305B-42FE-BFB3-3BECA88F52DEQ40720456-269A8278-79F9-4161-BB08-BFA035C17CA3Q41483867-F4E2D3DB-AA93-4E80-9887-F8DD0FD72147Q41857208-5F133800-E44B-48B7-BC57-DF158A27DA4BQ41916556-2993CEE9-3E73-4179-B95E-FCD76A54E32A
P2860
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
The role of HLA class I antige ...... nce for shared tumor antigens.
@en
The role of HLA class I antige ...... nce for shared tumor antigens.
@nl
type
label
The role of HLA class I antige ...... nce for shared tumor antigens.
@en
The role of HLA class I antige ...... nce for shared tumor antigens.
@nl
prefLabel
The role of HLA class I antige ...... nce for shared tumor antigens.
@en
The role of HLA class I antige ...... nce for shared tumor antigens.
@nl
P2093
P1476
The role of HLA class I antige ...... nce for shared tumor antigens.
@en
P2093
Seigler HF
Slingluff CL Jr
P304
P407
P577
1989-05-01T00:00:00Z